Finance

Lists
000538:SHE
Yunnan Baiyao Group Co Ltd
53,08 CN¥
+0,34%
(+0,18) 1D
16 қаз., 15:04:30 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000538...
Open
52,89 CN¥
High
53,66 CN¥
Low
52,52 CN¥
Mkt. cap
94,71 млрд
Avg. vol.
7,52 млн
Volume
12,92 млн
Dividend
4,94%
Quarterly dividend
0,66 CN¥
Ex-dividend date
2026 ж. 30 сәу.
P/E ratio
18,14
52-wk high
58,20 CN¥
52-wk low
46,29 CN¥
EPS
2,93 CN¥
Shares outstanding
1,78 млрд
No. of employees
9 мың
Open
52,89 CN¥
High
53,66 CN¥
Low
52,52 CN¥
Mkt. cap
94,71 млрд
Avg. vol.
7,52 млн
Volume
12,92 млн
Dividend
4,94%
Quarterly dividend
0,66 CN¥
Ex-dividend date
2026 ж. 30 сәу.
P/E ratio
18,14
52-wk high
58,20 CN¥
52-wk low
46,29 CN¥
EPS
2,93 CN¥
Shares outstanding
1,78 млрд
No. of employees
9 мың
News stories
From web sources and news partners
Profile
Yunnan Baiyao Group Co., Ltd is a Chinese pharmaceutical company that develops and manufactures pharmaceutical products and the wholesale and retail of pharmaceutical products. The Government Pension Fund of Norway has excluded the company from investments since 21 December 2021, since the company "uses and sells body parts from pangolins which is a globally endangered species". As of 2024, state and individual investors hold 29% of the shares and private companies hold 35%. The three largest shareholders hold 58 per cent of the company's shares. Wikipedia
About Yunnan Baiyao Group Co Ltd
CEO-
Employees9,29 мың
Founded1902
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
9,40 млрд
10,53 млрд
11,60 млрд
10,28 млрд
Cost of goods sold
6,70 млрд
7,85 млрд
8,05 млрд
7,28 млрд
Cost of revenue
6,70 млрд
7,85 млрд
8,05 млрд
7,28 млрд
Research and development expenses
79,10 млн
115,55 млн
76,79 млн
112,78 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,39 млрд
2,37 млрд
1,28 млрд
1,50 млрд
Operating expense
1,33 млрд
2,67 млрд
1,44 млрд
1,64 млрд
Total operating expenses
8,03 млрд
10,52 млрд
9,48 млрд
8,92 млрд
Operating income
1,37 млрд
12,79 млн
2,12 млрд
1,36 млрд
Other non operating income
-43,28 млн
135,88 млн
-17,44 млн
37,87 млн
EBT including unusual items
1,38 млрд
428,17 млн
2,36 млрд
1,92 млрд
EBT excluding unusual items
1,47 млрд
233,79 млн
2,35 млрд
1,74 млрд
Income tax expense
238,66 млн
27,40 млн
330,30 млн
255,01 млн
Effective tax rate
17,25%
6,40%
13,99%
13,27%
Other operating expenses
-18,86 млн
129,96 млн
6,54 млн
116,66 млн
Net income
1,14 млрд
376,37 млн
2,04 млрд
1,66 млрд
Net profit margin
12,18%
3,57%
17,56%
16,18%
Earnings per share
0,61
0,18
1,10
0,87
Interest and investment income
136,98 млн
107,27 млн
253,40 млн
367,65 млн
Interest expense
-4,39 млн
-8,83 млн
-5,09 млн
-5,15 млн
Net interest expenses
132,58 млн
98,43 млн
248,31 млн
362,50 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
1,42 млрд
70,91 млн
2,18 млрд
1,43 млрд
Gain or loss from assets sale
2,26 млн
-8,17 млн
-
-3,05 мың
AI content may include mistakes. Learn more
Google қолданбалары